Bluebird Bio Stock Analysis

Bluebird Stock Analysis Notes

About 44.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.73. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bluebird bio has Price/Earnings To Growth (PEG) ratio of 0.32. The entity recorded a loss per share of 1.8. The firm had not issued any dividends in recent years. Bluebird Bio had 1544:1000 split on the 5th of November 2021. bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts. Bluebird Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 518 people. For more info on Bluebird bio please contact Andrew Obenshain at 339 499 9300 or go to https://www.bluebirdbio.com.

Bluebird bio Investment Alerts

Bluebird bio Upcoming and Recent Events

Bluebird Largest EPS Surprises

View All Earnings Estimates

Bluebird Stock Institutional Investors

Note, although Bluebird Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bluebird Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 87.31 M.

Bluebird Profitablity

Management Efficiency

Bluebird bio has return on total asset (ROA) of (0.3624) % which means that it has lost $0.3624 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.867) %, meaning that it created substantial loss on money invested by shareholders. Bluebird Bio's management efficiency ratios could be used to measure how well Bluebird Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of December 11, 2024, Return On Tangible Assets is expected to decline to -0.37. In addition to that, Return On Capital Employed is expected to decline to -0.61. At present, Bluebird Bio's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 10.8 M, whereas Other Assets are forecasted to decline to about 33.2 M.

Technical Drivers

As of the 11th of December 2024, Bluebird Bio shows the Downside Deviation of 10.29, mean deviation of 6.3, and Risk Adjusted Performance of 0.0313. Bluebird bio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bluebird bio variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to decide if Bluebird bio is priced correctly, providing market reflects its regular price of 0.39 per share. As Bluebird bio appears to be a penny stock we also recommend to validate its total risk alpha numbers.

Bluebird bio Price Movement Analysis

Bluebird bio Insider Trading Activities

Bluebird Bio Outstanding Bonds

Bluebird Bio Predictive Daily Indicators

Bluebird Bio Forecast Models

Bluebird Bio's time-series forecasting models are one of many Bluebird Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bluebird Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bluebird Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bluebird shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bluebird Bio. By using and applying Bluebird Stock analysis, traders can create a robust methodology for identifying Bluebird entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bluebird analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bluebird analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Bluebird bio stock analysis indicators help investors evaluate how Bluebird Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bluebird Bio shares will generate the highest return on investment. By understating and applying Bluebird Bio stock analysis, traders can identify Bluebird Bio position entry and exit signals to maximize returns.

When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.